134 related articles for article (PubMed ID: 8714583)
1. Reactivation of fetal hemoglobin in patients with beta-thalassemia.
Olivieri NF
Semin Hematol; 1996 Jan; 33(1):24-42. PubMed ID: 8714583
[No Abstract] [Full Text] [Related]
2. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
Pearson HA
Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
[No Abstract] [Full Text] [Related]
3. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
[TBL] [Abstract][Full Text] [Related]
4. Reversing ontogeny.
Bunn HF
N Engl J Med; 1993 Jan; 328(2):129-31. PubMed ID: 7677964
[No Abstract] [Full Text] [Related]
5. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
[TBL] [Abstract][Full Text] [Related]
6. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
[TBL] [Abstract][Full Text] [Related]
7. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
Cario H; Wegener M; Debatin KM; Kohne E
Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
Cao H
Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea therapy in thalassemia.
Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Fathallah H; Sutton M; Atweh GF
Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
[TBL] [Abstract][Full Text] [Related]
11. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP;
Br J Haematol; 2005 Nov; 131(3):378-88. PubMed ID: 16225658
[TBL] [Abstract][Full Text] [Related]
12. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S
Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
Dover GJ
Ann N Y Acad Sci; 1998 Jun; 850():80-6. PubMed ID: 9668530
[TBL] [Abstract][Full Text] [Related]
16. A transgenic mouse model for studying the induction of fetal hemoglobin in the adult.
Constantoulakis P; Costantini F; Josephson B; Fry D; Mangahas L; Stamatoyannopoulos G
Trans Assoc Am Physicians; 1990; 103():80-9. PubMed ID: 1721467
[No Abstract] [Full Text] [Related]
17. Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.
Musallam KM; Taher AT; Cappellini MD; Sankaran VG
Blood; 2013 Mar; 121(12):2199-212; quiz 2372. PubMed ID: 23315167
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
[No Abstract] [Full Text] [Related]
19. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
Nienhuis AW; Ley TJ; Humphries RK; Young NS; Dover G
Ann N Y Acad Sci; 1985; 445():198-211. PubMed ID: 2409872
[No Abstract] [Full Text] [Related]
20. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]